Abstract
Bone-marrow transplantation is an approved curative treatment for many hemato- and oncologic diseases. Nevertheless, the severe acute clinical course of graft-vs-host disease (GVHD) after allogeneic bone-marrow transplantation is frequently fatal, and is to date not curable. Acute GVHD must, therefore, be prevented from the start of the bone-marrow transplantation by immunosuppressive medication, causing sometimes serious side effects. Therefore, new preventive strategies are tested, starting with animal experiments. Often mice are chosen for this kind of trial, and the clinical protocol of bone-marrow transplantation is transferred into the experimental settings. The first step to induce an acute GVHD is whole-body irradiation of the recipients. Several methods are available for this purpose: the most common is a 60cobalt source (γ-irradiation); less common are a 137cesium source (γ-irradiation) and a linear (particle) accelerator (photons). Differences between these radiation techniques can occur and can unexpectedly interfere with the results of the experiments. In this chapter, the materials and methods for bone-marrow transplantation in mice, with particular emphasis on the different radiation techniques, are explained; furthermore, the advantages and disadvantages in regard to the underlying physical principles will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Waer, M., Ang, K. K., Schueren, E. van der, and Vandeputte, M. (1984) Increased incidence of murine graft-versus-host disease after allogeneic bone marrow transplantation by previous infusion of syngeneic bone marrow cells. Transplantation 38, 396–400.
Eberl, G., Lees. R, Smiley, S. T., Taniguchi, M., Grusby, M. J., and MacDonald, H. R. (1999) Tissue-specific segregation of CD 1d-dependent and CD 1d-independent NK T cells. J. Immunol. 162, 6410–6419.
Zeng, D., Gazit, G., Dejbakhsh-Jones, S., et al. (1999) Heterogeneity of NK1.1-T cells in the bone marrow: divergence from the thymus. J. Immunol. 163, 5338–5345.
Rosario, M. L. U. del, Zucali, J. R., and Kao, K. J. (1999) Prevention of graft-versushost disease by induction of immune tolerance with ultraviolet b-irradiated leukocytes in H-2 disparate bone marrow donor. Blood 93, 3558–3564.
Zeng, D., Lewis, D., Dejbakhsh-Jones, S., et al. (1999) Bone marrow NK1.1-and NK1.1+T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189, 1073–1081.
Fauci, A. S. (1975) Human bone marrow lymphocytes: I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. J. Clin. Invest. 56, 98–110.
Zeng, D., Hoffmann, P., Lan, F., Huie, P., Higgins, J., and Strober, S. (2002) Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood 99, 1449–1457.
Sykes, M. (1990) Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8-and αβTCR+NK1.1+cells. J. Immunol. 145, 3209–3215.
Gombert, J. M., Herbelin, A., Tancrede-Bohin, E., Dy, M., Carnaud, C., and Bach, J. F. (1996) Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989–2998.
Baxter, A. G., Kinder, S. J., Hammond, K. J., Scollay, R., and Godfrey, D. I. (1997) Association between αβTCR+CD4-CD8-T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46, 572–582.
Hammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., and Baxter, A. G. (1998) α/β-T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL) 4 and/or IL-10. J. Exp. Med. 187, 1047–1056.
Palathumpat, V., Dejbakhsh-Jones, S., Holm, B., Wang, H., Liang, O., and Strober, S. (1992) Studies of CD4-CD8-αβ bone marrow T cells with suppressor activity. J. Immunol. 148, 373–380.
Sykes, M., Hoyles, K. A., Romick, M. L., and Sachs, D. H. (1990) In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+cell lines. Cell. Immunol. 129, 478–493.
Strober, S., Cheng, L., Zeng, D., et al. (1996) Double negative (CD4-CD8-αβ+) T cells which promote tolerance induction and regulate autoimmunity. Immunol. Rev. 149, 217–230.
Strober, S. (2000) Natural killer 1.1+T cells and "e;natural suppressor"e; T cells in the bone marrow. J. Allergy. Clin. Immunol. 106, S1 13–114.
Quast, U. and Hoederath, A. (1996) Ganzkörperbestrahlung. In: Strahlentherapie: Radiologische Onkologie. Scherer, E. and Sack, H. eds., Springer, New York, NY, pp. 207–218.
Richter, J. and Schwab, F. (1998) Charakterisierung und Eigenschaften von Dosisverteilungen, in Strahlenphysik für die Radioonkologie. Richter, J. and Flentje, M., eds., Thieme Stuttgart, New York, NY, pp. 43–59.
Verhey, L. J. (1998) Principles of radiation physics. In: Textbook of Radiation Oncology. Leibel, S. A. and Phillips, T. L. eds. WB Saunders, Philadelphia, PA, pp. 91–114.
Laubenberger, T. and Laubenberger, J. (eds.) (1994) Technik der medizinischen Radiologie: Diagnostik, Strahlentherapie, Strahlenschutzfür Ärzte, Medizinstudenten und MTRA; mit Anleitung zur Strahlenschutzbelehrung in der Röntgendiagnostik. Deutscher Ärzte-Verlag, Köln, Germany.
Schmidt, R. (1998) Geräte zur Erzeugung ionisierender Strahlung. In: Strahlenphysik für die Radioonkologie. Richter, J. and Flentje, M. eds. Thieme Stuttgart, New York, NY, pp. 27–38.
Sykes, M., Pearson, D. A., Taylor, P. A., Szot, G. L., Goldman, S. J., and Blazar, B. R. (1999) Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients. Biol. Blood Marrow Transplant. 5, 277–284.
Henning, U. G. G., Wang, Q., Gee, N. H., and von Borstel, R. C. (1996) Protection and repair of γ-radiation-induced lesions in mice with DNA or deoxyribonucleoside treatments. Mutat. Res. 350, 247–254.
Baker, M. B., Altman, N. H., Podack, E. R., and Levy, R. B. (1996) The role of cellmediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 184, 2645–2656.
Sprent, J., Schaefer, M., Gao, E. K., and Korngold, R. (1988) Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class IIH-2 differences. I. L3T4+cells can either augment or retard GVHD elicited by Lyt-2+cells in class Idifferent hosts. J. Exp. Med. 167, 556–569.
Sprent, J., Schaefer, M., and Korngold, R. (1990) Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. J. Immunol. 144, 2946–2954.
Graubert, T. A., Russell, J. H., and Ley, T. (1996) The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 87, 1232–1237.
Graubert, T. A., DiPersio, J. F., Russell, J. H., and Ley, T. J. (1997) Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J. Clin. Invest. 100, 904–911.
Korngold, R. and Sprent, J. (1985) Surface markers of T cells causing lethal graft-vs-host disease to class I vs class H-2 differences. J. Immunol. 135, 3004–3010.
Sprent, J., Schaefer, M., Lo, D., and Korngold, R. (1986) Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J. Exp. Med. 163, 998–1011.
Dey, B., Yang, Y. G., Preffer, F., Shimizu, A., Swenson, K., Dombkowski, D., and Sykes, M. (1999) The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation 68, 141–149.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Schwarte, S., Hoffmann, M.W. (2005). Influence of Radiation Protocols on Graft-vs-Host Disease Incidence After Bone-Marrow Transplantation in Experimental Models. In: Ludewig, B., Hoffmann, M.W. (eds) Adoptive Immunotherapy: Methods and Protocols. Methods in Molecular Medicine™, vol 109. Humana Press. https://doi.org/10.1385/1-59259-862-5:445
Download citation
DOI: https://doi.org/10.1385/1-59259-862-5:445
Publisher Name: Humana Press
Print ISBN: 978-1-58829-406-7
Online ISBN: 978-1-59259-862-5
eBook Packages: Springer Protocols